Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
ZR75B
HR+
Luminal
Cetuximab
EGFR
ErbB
9972.125
uM
4.30080
14.18760
0.8594 -0.8482 0.8310 0.0135
0.6892
1.1854
ZR75B
HR+
Luminal
CGC-11047
Polyamine analogue
9997.026
uM
694.32460
1000.00000
-0.6676 -0.5458 2.0226 0.2645
0.8363
1.1348
ZR75B
HR+
Luminal
CGC-11047
Polyamine analogue
9972.125
uM
62.05340
1000.00000
-0.5139 -0.9610 0.3858 0.3920
0.8676
1.1854
ZR75B
HR+
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9997.049
uM
inf
inf
0.9585 0.9585 0.0000 0.0082
0.0001
1.1423
ZR75B
HR+
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9972.017
uM
15.96770
42.6540
-0.7631 -1.0000 1.1181 0.2804
0.9966
1.1666
ZR75B
HR+
Luminal
CPT-11
TOP1
TOP
9997.121
uM
1.66170
0.86071
0.2842 0.3340 1.6759 0.2165
0.9826
1.1121
ZR75B
HR+
Luminal
CPT-11
TOP1
TOP
9972.121
uM
1.14060
0.77283
0.2080 0.2463 1.7425 0.2684
0.9929
1.1034
ZR75B
HR+
Luminal
Dactolisib
PI3K
PI3K
11939.155
uM
0.12564
0.09671
0.2549 0.2262 2.3010 0.3973
0.7606
1.6625
ZR75B
HR+
Luminal
Dichloroacetate
PDK
PDK
13595.176
uM
inf
inf
0.8559 0.8559 0.0000 0.0398
0.3144
1.9155
ZR75B
HR+
Luminal
Disulfiram
Proteasome
Proteasome
13595.174
uM
0.22129
0.11078
0.0054 0.4843 5.0000 0.2262
0.5901
1.8596
ZR75B
HR+
Luminal
Docetaxel
TUBB
TUBB
9972.002
uM
0.00317
0.00240
0.2383 0.2593 2.6193 0.4707
0.9839
1.0054
ZR75B
HR+
Luminal
Docetaxel
TUBB
TUBB
9997.002
uM
0.03585
0.01281
0.4029 0.4354 1.9886 0.2785
0.9894
0.9751
ZR75B
HR+
Luminal
Doxorubicin
TOP2
TOP
9997.121
uM
0.40220
0.87378
-0.9219 -0.7766 1.2081 0.6199
0.9828
1.1121
ZR75B
HR+
Luminal
Doxorubicin
TOP2
TOP
9972.121
uM
0.11460
0.30861
-0.7860 -0.7261 0.9054 0.7654
0.9839
1.1034
ZR75B
HR+
Luminal
Epirubicin
TOP2
TOP
9972.017
uM
0.10999
0.29245
-0.9953 -0.7491 0.9363 0.8467
0.9742
1.1666
ZR75B
HR+
Luminal
Erlotinib
EGFR
ErbB
7555.091
uM
222.88850
687.59880
0.7916 -0.8665 0.8924 0.0120
0.8409
1.6040
ZR75B
HR+
Luminal
Etoposide
TOP2
TOP
7555.074
uM
1.32870
4.60090
-0.0739 -0.2956 0.3739 0.4692
0.9938
1.6682
ZR75B
HR+
Luminal
Everolimus
MTOR
MTOR
11939.164
uM
0.19830
5.11160
-0.7640 -1.0000 0.3381 0.5367
0.8695
1.6455
ZR75B
HR+
Luminal
Fascaplysin
CDK4
CDK
7555.084
uM
0.38730
0.57572
-0.8819 -0.8758 2.5533 0.6163
0.9957
1.7052
ZR75B
HR+
Luminal
FR180204
ERK1/2
MAPK
11939.161
uM
113.17760
580.37840
0.5263 -1.0000 0.6721 0.1062
0.6994
1.6513
ZR75B
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
11939.154
uM
inf
inf
0.8647 0.8647 0.0000 0.0937
0.0531
1.7246
ZR75B
HR+
Luminal
Gefitinib
EGFR
ErbB
9997.049
uM
inf
inf
0.7909 0.7909 0.0000 0.0483
0.3558
1.1423
ZR75B
HR+
Luminal
Gefitinib
EGFR
ErbB
9997.024
uM
7.45070
7.79640
-0.1265 -0.1273 4.9980 0.1364
0.8935
0.9704
ZR75B
HR+
Luminal
Gefitinib
EGFR
ErbB
9972.019
uM
18.13440
23.14480
-0.3622 -0.7215 3.6614 0.0934
0.990
1.0654
ZR75B
HR+
Luminal
Geldanamycin
HSP90
HSP90
9997.049
uM
0.10140
0.04753
0.1808 0.3301 1.4243 0.3756
0.8932
1.1423